Timmerman Report
The Long Run with Luke Timmerman
"The Long Run"Antarctic explorer Ernest Shackleton would appreciate today's biotech. Scientific entrepreneurs of the 21st century must be ready for what Shackleton called the “hazardous journey, bitter cold, long months of complete darkness, constant danger, safe return doubtful, honor and recognition in case of success.” Today, the men and women who strive to apply science for the betterment of human health have a historic opportunity. They need stamina and resilience to achieve something meaningful. Biotech’s relationship with the society that sustains it has never been more tenuous. Join ho...
Where to listen?
Podcasts in the app Replaio Radio Coming soonPodcasts are coming to the app soon. Install now and be the first to see a whole new take on podcasts
Install for free
Android 5M+ downloads · 4.8 rating
iOS soon
Episodes
Ep129: Joanne Smith-Farrell on Engineered B-Cell Therapies 14.02.2023 1:11:43
Joanne Smith-Farrell, CEO of Cambridge, Mass.-based Be Biopharma, on Engineered B-Cell Therapies for Cancer & Rare Diseases.
Ep128: Rick Berke on Building a Biotech Journalism Outlet to Last 01.02.2023 1:00:34
Rick Berke, co-founder and executive editor of STAT, on building a biotech journalism outlet to last.
Ep127: Jeb Keiper on Computational Drug Discovery 20.01.2023 1:09:41
Jeb Keiper, CEO of Nimbus Therapeutics, on computational drug discovery, an unusual business model, and an important new Tyk2 inhibitor for psoriasis and other forms of autoimmunity.
Ep126: DA Wallach on Becoming a Biotech VC 03.01.2023 1:11:38
DA Wallach, founder and general partner of TIME Bioventures, on becoming a biotech venture investor.
Ep125: Barry Greene on a New Drug for Depression 19.12.2022 1:04:52
Barry Greene, CEO of Cambridge, Mass.-based Sage Therapeutics, on plans to introduce a new type of treatment for depression and postpartum depression.
Ep124: Shehnaaz Suliman on Delivery of Genetic Medicines 08.11.2022 1:09:53
Shehnaaz Suliman, CEO of ReCode Therapeutics, on lipid nanoparticle delivery of genetic medicines.
Ep123: Tariq Kassum on Single-Cell Analysis for Drug Discovery 27.10.2022 1:15:26
Tariq Kassum, CEO of Cambridge, Mass.-based Celsius Therapeutics, on using single cell technology for drug discovery.
Ep122: Aetna Wun Trombley on Extracellular Protein Degraders 11.10.2022 1:00:04
Aetna Wun Trombley, CEO of Lycia Therapeutics, on extracellular protein degraders.
Ep121: Samantha Truex on Going Upstream Against Severe Asthma 26.09.2022 1:03:49
Samantha Truex, CEO of Upstream Bio, on a new approach to treating severe asthma and other inflammatory diseases.
Ep120: Tim Lu on Gene Circuits for Cell Therapy 07.09.2022 1:04:14
Tim Lu, CEO of Senti Biosciences, on developing gene circuits for cell therapy.
Ep119: Jo Viney on Discovering Treatments for Autoimmune Disease 22.08.2022 1:02:42
Jo Viney, CEO of Seismic Therapeutic, on discovering new treatments for autoimmune disease.
Ep118: Ivan Liachko on Assembling Accurate Genomes and Interactomes 08.08.2022 1:08:08
Ivan Liachko, CEO of Seattle-based Phase Genomics, on assembling accurate genomes and interactomes. He also discusses immigrating from Ukraine as a child, and what brought him and his family to the US.
Ep117: Dr. Sanduk Ruit on Restoring Eyesight in the Developing World 11.07.2022 1:01:24
Dr. Sanduk Ruit of the Tilganga Institute in Kathmandu on restoring eyesight with affordable cataract surgery for the developing world.
Ep116: Ivana Magovcevic-Liebisch on Precision Neuroscience 22.06.2022 58:35
Ivana Magovcevic-Liebisch, CEO of Vigil Neuroscience, on precision neuroscience drug development.
Ep115: Rahul Singhvi on Reimagining Biotech Manufacturing 07.06.2022 59:21
Rahul Singhvi, CEO of Resilience, on rethinking the model for manufacturing of advanced biologics, gene and cell therapies.
Ep114: Chris Gibson on Industrializing Drug Discovery 23.05.2022 1:06:33
Chris Gibson, co-founder and CEO of Recursion, on using new tools to industrialize drug discovery.
Ep113: Lewis Cantley & Siddhartha Mukherjee on Fighting Cancer with Food and Drugs 09.05.2022 40:07
Lewis Cantley and Siddhartha Mukherjee, co-founders of Faeth Therapeutics, on fighting cancer with food and drug combinations.
Ep112: Bernat Olle on Microbiome Therapeutics 18.04.2022 1:06:26
Bernat Olle, CEO of Vedanta Biosciences, on developing microbiome therapeutics.
Ep111: Ray Stevens on Structural Biology-Driven Drug Discovery 14.03.2022 1:02:42
Ray Stevens, CEO of ShouTi, on structural biology driven drug discovery.
Ep110: Michele Andrasik on Making Clinical Trials More Diverse 01.03.2022 1:07:25
Michele Andrasik, a clinical health psychologist at the Fred Hutchinson Cancer Research Center, on improving community outreach and diversity in clinical trials.
Ep109: Derrell Porter on Cell Therapy Commercialization 15.02.2022 1:08:52
Derrell Porter, CEO of CellEvolve, on a new approach to commercializing cell therapies.
Ep108: Praveen Tipirneni on Targeting Integrins With Small Molecules 31.01.2022 1:11:26
Praveen Tipirneni, CEO of Morphic Therapeutic, on targeting integrins with small molecules.
Ep107: Bassil Dahiyat on Antibody Engineering & Company Building 11.01.2022 1:04:02
Bassil Dahiyat of Xencor on antibody engineering and company building.
Ep106: Vineeta Agarwala on Health Data & VC Investing 20.12.2021 1:11:11
Vineeta Agarwala, general partner with Andreesen Horowitz's bio fund, on investing in therapeutics, diagnostics and digital health.
Ep105: Nello Mainolfi on Targeted Protein Degraders 06.12.2021 1:08:09
Nello Mainolfi, CEO of Kymera Therapeutics, on targeted protein degrading small molecule drugs.
Similar podcasts
Listen to the The Long Run with Luke Timmerman podcast in Replaio
Radio and podcasts in one app - free, with no sign-up. Install today and do not miss the launch
Replaio is not a podcast publisher; show names, artwork and audio belong to their authors and are distributed through public RSS feeds.
